Precision BioSciences (DTIL) Earnings Analysis
Precision BioSciences (DTIL) next reports earnings on 2026-08-06, consensus EPS -0.71 USD. Last quarter (2026-03-12) it beat with EPS 0.36 USD vs -0.21 USD est (+271.4%). It has beaten estimates in 2/6 recent quarters (33%). Trailing P/E -2.00.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does DTIL next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -0.71 USD |
| Revenue estimate | 0.00B |
DTIL earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-12 | 0.36 USD | -0.21 USD | +271.4% | Beat |
| 2025-11-03 | -1.84 USD | -0.31 USD | -493.5% | Miss |
| 2025-08-07 | -2.13 USD | -0.09 USD | -2266.7% | Miss |
| 2025-05-15 | -2.21 USD | -0.43 USD | -414% | Miss |
| 2024-11-04 | -2.83 USD | -0.79 USD | -258.2% | Miss |
| 2024-08-01 | 3.46 USD | -0.77 USD | +549.4% | Beat |
Beat rate: 2/6 (33%) over reported quarters with consensus data.
DTIL valuation and analyst view
| Trailing P/E | -2.00 |
|---|---|
| Trailing EPS | -1.76988 USD |
| Price / book | 2.37 |
| Dividend yield | 0.00% |
| Market cap | 0.09B |
| Analyst consensus | Buy (9 buy / 3 hold / 0 sell) |
| Avg price target | 20 USD |
Related research pages
Frequently asked questions
When is Precision BioSciences (DTIL)'s next earnings date?
Precision BioSciences is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.71 USD and revenue estimate of 0.00B.
Did DTIL beat earnings last quarter?
In its 2026-03-12 report, DTIL posted EPS of 0.36 USD versus a -0.21 USD estimate — a beat of 271.4%.
What is DTIL's earnings track record?
Over the last 6 reported quarters with consensus data, DTIL beat estimates 2 times (33%).
What is DTIL's current P/E ratio and EPS?
DTIL trades at a trailing P/E of -2.00 on trailing EPS of -1.7698796761915827 USD.
What do analysts rate DTIL?
Analyst consensus is "Buy" across 12 ratings (0 strong buy, 9 buy, 3 hold, 0 sell, 0 strong sell). Average 12-month price target: 20 USD.